April 8 (Reuters) - Generic drugmaker Mylan NV said on Wednesday it has offered to buy Perrigo Co Plc for about $29 billion in cash and stock in a move that would significantly beef up Mylan's offerings of over-the-counter consumer products.
Mylan said it proposed to acquire the Ireland-based company for $205 per share, representing more than a 25 percent premium over Perrigo's April 3 closing price, the last trading day prior to the Mylan proposal.
21:31 Time Warner jumps after hours on report it could sell for $110 per share to AT&T3
12:23 Lockheed Martin's quarterly profit handily beats estimates13
11:41 Caterpillar earnings: 85 cents per share, vs expected EPS of 76 cents14
18:04 US stocks hold higher after release of Fed's Beige Book; energy rises 2%1